Skip to content
bioprocess.updates

Cell & Gene Therapy

Cell and gene therapy manufacturing covers how viral vectors (AAV, lentivirus), CAR-T and other cell therapies are produced, purified and scaled under GMP. This section follows process development, platforms and new capacity at CDMOs and developers, from papers, regulators and company data. Start with scaling up lentiviral vector production with perfusion and automated GMP manufacturing of edited CAR-T cells.

10 pieces